[go: up one dir, main page]

GB201001596D0 - S100 protein binding interaction inhibitors - Google Patents

S100 protein binding interaction inhibitors

Info

Publication number
GB201001596D0
GB201001596D0 GBGB1001596.4A GB201001596A GB201001596D0 GB 201001596 D0 GB201001596 D0 GB 201001596D0 GB 201001596 A GB201001596 A GB 201001596A GB 201001596 D0 GB201001596 D0 GB 201001596D0
Authority
GB
United Kingdom
Prior art keywords
protein binding
binding interaction
interaction inhibitors
inhibitors
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1001596.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GBGB1001596.4A priority Critical patent/GB201001596D0/en
Publication of GB201001596D0 publication Critical patent/GB201001596D0/en
Priority to PCT/GB2011/050137 priority patent/WO2011092505A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1001596.4A 2010-02-01 2010-02-01 S100 protein binding interaction inhibitors Ceased GB201001596D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1001596.4A GB201001596D0 (en) 2010-02-01 2010-02-01 S100 protein binding interaction inhibitors
PCT/GB2011/050137 WO2011092505A1 (en) 2010-02-01 2011-01-28 S100 protein binding interaction inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1001596.4A GB201001596D0 (en) 2010-02-01 2010-02-01 S100 protein binding interaction inhibitors

Publications (1)

Publication Number Publication Date
GB201001596D0 true GB201001596D0 (en) 2010-03-17

Family

ID=42084271

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1001596.4A Ceased GB201001596D0 (en) 2010-02-01 2010-02-01 S100 protein binding interaction inhibitors

Country Status (2)

Country Link
GB (1) GB201001596D0 (en)
WO (1) WO2011092505A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603717A (en) * 2012-01-09 2012-07-25 中国人民解放军第二军医大学 Pyrrylketone compound and application thereof as drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868685A2 (en) * 2005-03-18 2007-12-26 onepharm GmbH 11ß-HYDROXYSTEROID DEHYDROGENASES
US8138356B2 (en) * 2007-10-16 2012-03-20 Angiogeney, Inc. Chemical inhibitors of inhibitors of differentiation
FR2929851B1 (en) * 2008-04-09 2012-11-30 Centre Nat Rech Scient MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE TYROSINE KINASE SYK PROTEIN AND METHOD OF IDENTIFYING SAID MOLECULES
EP2336109A4 (en) * 2008-09-25 2012-05-02 Shionogi & Co Novel pyrrolinone derivative and medicinal composition containing same

Also Published As

Publication number Publication date
WO2011092505A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
IL271804A (en) Mice that make binding proteins
LTPA2019012I1 (en) Plasma calcitrin binding proteins
IL222323A0 (en) Tnf - alpha binding proteins
IL222980A0 (en) Il-1 binding proteins
ZA201300975B (en) Binding proteins for hepcidin
ZA201304905B (en) TNF-a BINDING PROTEINS
ZA201206552B (en) Therapeutic dll4 binding proteins
ZA201205624B (en) Cd127 binding proteins
HK1202444A1 (en) Il-1 binding proteins il-1
IL226157A0 (en) Antigen binding proteins
EP2569338A4 (en) Binding systems
SG10201503080XA (en) Eif4e binding peptides
GB201001596D0 (en) S100 protein binding interaction inhibitors
TWM400980U (en) Binding
GB201013489D0 (en) Binding surfaces
GB201003906D0 (en) Binding polypeptides
GB201010143D0 (en) Comb binding

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)